Research News

Filter News By

Clear Filters

  1. Cystic Fibrosis Foundation Announces Nine Research Agreements to Advance Its Path to a Cure

    December 10, 2020

    The Cystic Fibrosis Foundation announced a new set of research agreements to drive progress on its Path to a Cure. The nine awards will advance a variety of tools and strategies to accelerate treatments for the underlying cause of cystic fibrosis for all people with CF, regardless of their mutations.

  2. CF Foundation Awards up to $3.75M to Matinas BioPharma to Develop Oral Version of Antibiotic for NTM Infections

    November 20, 2020

    Potential oral formulation of drug targeting nontuberculous mycobacteria infections could reduce side effects of current treatment

  3. CF Foundation Awards up to $2.4M for a New Approach to Reduce Infections

    November 2, 2020

    Potential treatment from Calithera Biosciences minimizes growth of germs in the lungs

  4. CF Foundation Awards Nearly $15 Million to Spur Infection Research

    August 24, 2020

    Thirty-three new projects are being funded as part of the Foundation’s $100 million Infection Research Initiative.

  5. CF Foundation Invests up to $14M in Effort to Solve Key Challenges to Gene Delivery in Cystic Fibrosis

    June 17, 2020

    The Cystic Fibrosis Foundation announced an investment in 4D Molecular Therapeutics to develop a customized vehicle to deliver a healthy CFTR gene into the lung cells of people with CF.

  6. CF Foundation Awards Up to $5.6 Million to Develop Novel Antibiotic to Fight Drug-Resistant Bacteria

    May 28, 2020

    The Cystic Fibrosis Foundation has awarded up to $5.6 million to Microbion Corporation to develop a novel, inhaled antibiotic to treat drug-resistant bacterial infections in people with cystic fibrosis.
More Posts View All Posts

Follow Us On